Which statement is NOT a requirement for prescribing and dispensing sodium valproate?

Which statement is NOT a requirement for prescribing and dispensing sodium valproate?

• A. Under no circumstances should women or girls take sodium valproate
• B. Sodium Valproate must be supplied with a Warning label on the packaging
• C. Sodium Valproate must be dispensed in Whole packs
• D. Sodium Valproate must be prescribed by a specialist in neurology

Answer: (A)

The key idea here is how valproate is regulated to minimize fetal risk. Because valproate is highly teratogenic, rules focus on risk minimization: warning materials, careful patient selection, and involvement of specialists to ensure pregnancy prevention and monitoring. The statement that says no woman or girl should ever take valproate is not a requirement. In practice, valproate can be prescribed to women of childbearing potential only when the benefits clearly outweigh the risks and with strict safeguards in place—such as thorough counseling, confirmation of effective contraception, regular pregnancy testing, and close monitoring. It’s about controlled use, not an absolute ban. The other statements reflect actual safeguards: - A warning label on packaging ensures patients and caregivers are aware of the serious risks from the outset. - Dispensing in whole packs helps maintain consistent dosing and reduces opportunities for incomplete courses that could complicate safety monitoring. - Prescribing by a specialist (often in neurology or epilepsy care) ensures appropriate assessment, planning, and implementation of the pregnancy prevention plan and ongoing safety monitoring. So, the blanket prohibition is not a requirement, while the other measures are.

The key idea here is how valproate is regulated to minimize fetal risk. Because valproate is highly teratogenic, rules focus on risk minimization: warning materials, careful patient selection, and involvement of specialists to ensure pregnancy prevention and monitoring.

The statement that says no woman or girl should ever take valproate is not a requirement. In practice, valproate can be prescribed to women of childbearing potential only when the benefits clearly outweigh the risks and with strict safeguards in place—such as thorough counseling, confirmation of effective contraception, regular pregnancy testing, and close monitoring. It’s about controlled use, not an absolute ban.

The other statements reflect actual safeguards:

• A warning label on packaging ensures patients and caregivers are aware of the serious risks from the outset.

• Dispensing in whole packs helps maintain consistent dosing and reduces opportunities for incomplete courses that could complicate safety monitoring.

• Prescribing by a specialist (often in neurology or epilepsy care) ensures appropriate assessment, planning, and implementation of the pregnancy prevention plan and ongoing safety monitoring.

So, the blanket prohibition is not a requirement, while the other measures are.